Skip to main content

Posts

Showing posts from February, 2023

Lindsay Dudfield, Executive Director and CEO of Jindalee Resources Limited, Executed MOU with POSCO Holdings For Joint Research At McDermitt Lithium Project

JINDALEE RESOURCES LIMITED  (ASX: JRL) (Jindalee, the Company) is an Australian exploration company with Tier 1 lithium deposits in its portfolio in the United States. The Company’s core goals are to discover world-class mineral deposits and generate shareholder wealth. The United States is one of the largest marketplaces for lithium demand, and Jindalee is a leading company committed to help meet future demand. The Company is focussing efforts into developing its McDermitt lithium deposit. Jindalee Resources was listed on the Australian Securities Exchange (ASX) on 11th July 2002 and raised AUD 2.70 million. Now, it is a pure-play United States lithium company. Jindalee’s Projects: In June 2018, the Company acquired McDermitt and Clayton North, two lithium sediment projects in the United States. Both projects are 100% owned by HiTech Minerals Inc., a wholly owned, US-based subsidiary of Jindalee. Several factors attracted the Company’s interest in these projects including: Potentially
Post a Comment
Read more

VRX Silica Reports A Productive December 2022 Quarter

Here is an overview of VRX Silica’s progress during the December 2022 quarter. Critical Minerals Publication The Austrade Critical Minerals Prospectus 2022 Edition, published by the Australian Trade and Investment Commission, included  VRX SILICA’S  Arrowsmith North and Muchea silica sand projects. So far, the critical minerals prospectus has gained compelling recognition among interested foreign investors and buyers, Australian corporates, and the Australian government. The prospectus highlighted the potential of VRX Silica’s silica sand projects to address anticipated production shortfalls, build supply chain security, and aid a net-zero future, which can be a significant step forward for the Company. The publication will also promote VRX products to potential buyers and investors overseas. VRX Silica will continue to contact potential buyers who received samples of products from Arrowsmith North and Muchea silica sand projects. Silica Sand Project Advancements VRX  ensures a discipl
Post a Comment
Read more

Calima Energy And CEO Jordan Kevol Are All-Set For The Strategic Retesting Program In Montney

CALIMA ENERGY  (ASX: CE1)  unveils the initiation of an effective testing program on the two long-reach horizontal Montney wells drilled and partially tested in 2019 on the Calima Lands. With this, Calima Energy and  CEO JORDAN KEVOL  intend to de-risk the project and are expected to generate a higher value for the asset, aiming to complete a joint venture, partnership, or trade sale. The operation of one of the top-tier mining companies in Australia will gauge the gas and condensate flow rates of the Middle Montney Formation in Calima #2. In addition, it will allow for a longer-term test on the Upper Montney in the Calima #3 well. The abundance of condensate and NGLs will further upscale the project economics for prospective  CALIMA ENERGY PROJECTS . Currently, the project is funded by cash flow derived from the production activities in the Brooks and Thorsby assets, with current production of around 4,500 boe/d. The latest Calima Energy share price is  AUD0.145 . Due to the early spr
Post a Comment
Read more

Roquefort Therapeutics Reports In-Vivo Safety For Midkine Oncology Antibodies

ROQUEFORT THERAPEUTICS (LSE: ROQ, OTCQB: ROQAF)  (“Roquefort” or the “Company”)  ANNOUNCES  that two of its Midkine (MDK) antibody programs, ROQ-A1 and ROQ-A2, demonstrate  in-vivo  safety in the pre-clinical development programs. The pre-clinical programs were carried out by leading cancer research groups. ROQ-A1 and ROQ-A2 are two patented antibody medicines designed by Roquefort to target metastatic breast cancer and metastatic lung cancer. The experiments demonstrated that ROQ-A1 and ROQ-A2 bind specifically to MDK receptors in cancerous cells in the breast and lung and kill cancer  in vitro . Antibody programs targeting metastatic lung and breast cancer commenced in Q4 2022 at Olivia Newton-John Cancer Research Institute (La Trobe University), Hawkins Laboratory Biochemistry and Genetics (La Trobe University). Both antibodies have demonstrated good safety profiles validated in  in-vivo  models. The targets and milestones were achieved within budget and on time.     AJAN REGINALD ,
Post a Comment
Read more

Eclipse Metals Reports A Busy December 2022 Quarter

ECLIPSE METALS  (ASX: EPM and FSE: 9EU) (Eclipse or the Company) has released its quarterly report highlighting the project advancements and other activities during the December 2022 quarter. Here are the updates on the activities carried out by Eclipse. Multi-commodity Greenland Project Updates ECLIPSE METALS  has completed the maiden percussion drilling and trench sampling program at its SW Greenland multi-commodity project. Initial stages of exploration at Ivigtût mine precinct and Grønnedal carbonatite were completed in November 2022. Grønnedal Carbonatite Complex Thirty-one drill holes over a ~3.0km by ~1.5km area to vertical depths of between 3m and 22m were completed at the Grønnedal carbonatite complex, and trenches were excavated where drilling was impossible. The drill samples taken at Greenland were tested using a portable XRF (pXRF) analyser. Grønnedal carbonatite complex shows favourable praseodymium (Pr) and neodymium (Nd) ratios and may have global significance due to th
Post a Comment
Read more

Carbonxt Group Releases Its December 2022 Quarterly Report

R&D and Industry Activities Carbonxt’s research and development team completed a program focusing on ‘the effects of heat treatment on Activated Carbon’ with the help of a renowned R&D service company. The research output is favourable and supports the development of Carbonxt’s new ACP plant in Kentucky. CARBONXT GROUP  also attended the North American Biochar and Bioenergy Conference about biomass utilisation for bioenergy production, pertaining to the Company’s focus on ESG objectives and the use of renewable sources of raw material for producing Powdered Activated Carbon (PAC) at its Black Birch plant. The  COMPANY  expects moderation of prices for Activated Carbon products manufactured overseas, given the decrease in ocean shipping rates to import products into the US. However, industrial customers continue to show a strong preference for domestically produced PAC and Activated Carbon Pellet (ACP) products. Customer receipts Customer receipts decreased by 24% compared to th
Post a Comment
Read more